These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Encainide and flecainide in children: separating the wheat from the chaff. Perry JC, Garson A. J Am Coll Cardiol; 1991 Aug; 18(2):366-7. PubMed ID: 1906903 [No Abstract] [Full Text] [Related]
13. Sinus node dysfunction and sudden cardiac death following treatment with encainide. Lemery R, Talajic M, Nattel S, Theroux P, Roy D. Pacing Clin Electrophysiol; 1989 Oct 19; 12(10):1607-12. PubMed ID: 2477816 [Abstract] [Full Text] [Related]
14. Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugs. Feld GK, Chen PS, Nicod P, Fleck RP, Meyer D. Am J Cardiol; 1990 Aug 01; 66(3):378-83. PubMed ID: 2114784 [No Abstract] [Full Text] [Related]
16. Encainide-induced encephalopathy in a patient with chronic renal failure. Tartini A, Kesselbrenner M. Am J Kidney Dis; 1990 Feb 01; 15(2):178-9. PubMed ID: 2105639 [Abstract] [Full Text] [Related]
17. Comparison of encainide and quinidine for supraventricular tachyarrhythmias. Mäkynen PJ, Koskinen PJ, Saaristo TE, Liisanantti RK. Am J Cardiol; 1988 Dec 20; 62(19):55L-59L. PubMed ID: 3144169 [Abstract] [Full Text] [Related]